SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 66 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $638,614 | -26.9% | 43,982 | +5.4% | 0.00% | – |
| Q2 2023 | $873,716 | -50.2% | 41,745 | -49.8% | 0.00% | – |
| Q1 2023 | $1,754,680 | +67.2% | 83,082 | +101.5% | 0.00% | – |
| Q4 2022 | $1,049,144 | -73.7% | 41,224 | -75.1% | 0.00% | – |
| Q3 2022 | $3,986,000 | +64.8% | 165,873 | +32.0% | 0.00% | – |
| Q2 2022 | $2,418,000 | -26.3% | 125,656 | -33.4% | 0.00% | – |
| Q1 2022 | $3,280,000 | -20.0% | 188,743 | +0.7% | 0.00% | – |
| Q4 2021 | $4,101,000 | +45.6% | 187,349 | -46.3% | 0.00% | – |
| Q3 2018 | $2,817,000 | -28.4% | 348,653 | -37.8% | 0.00% | – |
| Q2 2018 | $3,933,000 | -50.7% | 560,202 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $7,972,000 | +29.5% | 560,202 | -20.3% | 0.00% | 0.0% |
| Q4 2017 | $6,157,000 | -52.1% | 702,844 | -36.0% | 0.00% | -50.0% |
| Q3 2017 | $12,841,000 | -31.5% | 1,097,551 | -18.2% | 0.00% | 0.0% |
| Q2 2017 | $18,743,000 | +9.3% | 1,341,644 | +7.3% | 0.00% | 0.0% |
| Q1 2017 | $17,154,000 | +61.6% | 1,250,316 | -15.5% | 0.00% | +100.0% |
| Q4 2016 | $10,612,000 | -66.6% | 1,480,047 | -29.3% | 0.00% | -75.0% |
| Q3 2016 | $31,752,000 | +53.9% | 2,094,464 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $20,630,000 | -26.1% | 2,094,464 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $27,898,000 | – | 2,094,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $24,631,000 | 16.36% |
| Kynam Capital Management, LP | 2,272,915 | $54,618,000 | 11.51% |
| Frazier Life Sciences Management, L.P. | 3,412,838 | $82,010,000 | 6.32% |
| Foresite Capital Management IV, LLC | 690,000 | $16,581,000 | 5.33% |
| Paradigm Biocapital Advisors LP | 1,085,142 | $26,076,000 | 3.48% |
| ACUTA CAPITAL PARTNERS, LLC | 324,614 | $7,800,000 | 3.36% |
| COMMODORE CAPITAL LP | 738,110 | $17,737,000 | 2.85% |
| SPHERA FUNDS MANAGEMENT LTD. | 822,696 | $19,769,000 | 2.74% |
| Avidity Partners Management LP | 5,586,900 | $134,253,000 | 2.73% |
| HealthCor Management, L.P. | 859,240 | $20,648,000 | 2.58% |